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Kingella kingae is an emerging bacterial pathogen that is being recognized increasingly as an important etiology of septic arthri-
tis, osteomyelitis, and bacteremia, especially in young children. The pathogenesis of K. kingae disease begins with bacterial ad-
herence to respiratory epithelium, which is dependent on type IV pili and is influenced by two PilC-like proteins called PilC1 and
PilC2. Production of either PilC1 or PilC2 is necessary for K. kingae piliation and bacterial adherence. In this study, we set out to
further investigate the role of PilC1 and PilC2 in type IV pilus-associated phenotypes. We found that PilC1 contains a functional
9-amino-acid calcium-binding (Ca-binding) site with homology to the Pseudomonas aeruginosa PilY1 Ca-binding site and that
PilC2 contains a functional 12-amino-acid Ca-binding site with homology to the human calmodulin Ca-binding site. Using tar-
geted mutagenesis to disrupt the Ca-binding sites, we demonstrated that the PilC1 and PilC2 Ca-binding sites are dispensable
for piliation. Interestingly, we showed that the PilC1 site is necessary for twitching motility and adherence to Chang epithelial
cells, while the PilC2 site has only a minor influence on twitching motility and no influence on adherence. These findings estab-
lish key differences in PilC1 and PilC2 function in K. kingae and provide insights into the biology of the PilC-like family of
proteins.
Kingella kingae is a Gram-negative organism that belongs to theNeisseriaceae family and is being recognized increasingly as an
important pathogen in young children. Improvements in culture-
based and molecular diagnostics have identified K. kingae as a
common etiology of septic arthritis, osteomyelitis, and bacteremia
in the pediatric population (1–8). A recent study reported K. kin-
gae as the leading cause of septic arthritis in children 6 to 36
months of age (1). Based on epidemiological studies, K. kingae is
believed to initiate infection by colonizing the posterior pharynx,
where it typically persists for weeks without producing symptoms
(9–12). On occasion, the organism will breach the epithelial bar-
rier and enter the bloodstream and then disseminate hematog-
enously to the joints, bones, or endocardium (6, 8). This model is
supported by reports describing genotypically identical K. kingae
paired isolates from the respiratory tract and blood of patients
with invasive K. kingae disease (11, 13). Despite increased recog-
nition of K. kingae as an important pathogen, little is known about
the molecular mechanisms used by this organism to cause disease.
Previous work established that K. kingae produces type IV pili
that are necessary for adherence to respiratory epithelial and sy-
novial cells (14–16). Type IV pili are surface fibers that are wide-
spread in Gram-negative bacteria and convey many phenotypes,
including adherence, twitching motility, and natural competence
(17, 18). These fibers are composed primarily of a single protein
subunit (called PilA1 in K. kingae) and require numerous other
factors for proper production. A key aspect of type IV pilus biol-
ogy and the associated phenotypes is the ability of the fiber to be
retracted through the outer membrane, a process catalyzed by the
retraction ATPase, PilT, and associated with twitching motility
(19–23). While many of the protein factors involved in type IV
pilus biology have been well studied, the mechanism controlling
pilus extension and pilus retraction remains poorly understood.
However, current data from work on the pathogenic Neisseria
species (Neisseria meningitidis and Neisseria gonorrhoeae) and
Pseudomonas aeruginosa suggests that counteraction of retraction
by PilC-like proteins is required for proper pilus production and
twitching motility (24–26).
The PilC proteins are proposed to influence two aspects of type
IV pilus biology, namely, pilus biogenesis and adherence. Like N.
meningitidis and N. gonorrhoeae, K. kingae produces two PilC-like
proteins called PilC1 and PilC2, which are encoded by genes at
separate locations in the genome (14, 27, 28). The PilC1 and PilC2
proteins in the pathogenic Neisseria species have been identified as
the adhesive component of the pilus fiber and are located at the tip
of the fiber in N. gonorrhoeae (29–31). Recent observations suggest
that P. aeruginosa PilY1 (the single PilC-like protein in P. aerugi-
nosa) is also an adhesin (25, 32). In earlier work, we observed a
reduction in adherence to human cells by K. kingae strain 269-492
derivatives that expressed only PilC1 or PilC2, supporting a po-
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tential role for these proteins in adherence (14). In addition, we
found that elimination of both PilC1 and PilC2 in K. kingae strain
269-492 resulted in a loss of piliation, suggesting that at least one
PilC protein is required for pilus production (14). Similar results
were obtained with the pathogenic Neisseria species and P. aerugi-
nosa (27, 33). Recently, P. aeruginosa PilY1 was shown to regulate
pilus production and twitching motility through calcium binding
(Ca binding) at a 9-amino-acid loop in the C-terminal domain
(34). Using bioinformatic approaches, similar loops were identi-
fied in other PilC homologs, including N. meningitidis and N.
gonorrhoeae PilC1 and PilC2 and K. kingae PilC1, but not PilC2
(34).
In contrast to the PilC1 and PilC2 proteins in N. gonorrhoeae
and N. meningitidis, K. kingae PilC1 and PilC2 share only limited
overall sequence homology (7% identity and 16% similarity) (14).
In this regard, K. kingae represents a unique and intriguing system
to investigate PilC-like protein biology. In this study, we examined
Ca binding by PilC1 and PilC2 and the potential role of Ca binding
in control of type IV pilus production, twitching motility, and
adherence to Chang epithelial cells. We report that both PilC1 and
PilC2 bind calcium, with PilC1 utilizing a 9-amino-acid PilY1-like
Ca-binding site and PilC2 utilizing a 12-amino-acid human
calmodulin-like Ca-binding site. While both the PilC1 and PilC2
Ca-binding sites are dispensable for pilus production, the PilC1
Ca-binding site is required for twitching motility and adherence.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains used in this study are listed in Table 1.
K. kingae strains were stored at 80°C in brain heart infusion broth (BHI)
with 30% glycerol. K. kingae strain KK03 is a stable high-level pilus-ex-
pressing, spreading-corroding colony type (bacterial growth spreads from
the central raised colony, and colony expansion results in pitting or cor-
roding of the agar surface) of clinical isolate 269-492. E. coli strains were
stored at 80°C in Luria-Bertani (LB) broth with 15% glycerol. K. kingae
strains were routinely cultured at 37°C with 5% CO2 on chocolate agar
supplemented with 50 g/ml kanamycin, 1 g/ml erythromycin, or 2
g/ml tetracycline, as appropriate. E. coli strains were routinely cultured
at 37°C in LB broth or on LB agar supplemented with 100 g/ml ampicil-
lin, 50 g/ml kanamycin, 500 g/ml erythromycin, 25 g/ml tetracycline,
50 g/ml streptomycin, or 50 g/ml chloramphenicol, as appropriate.
Recombinant PilC constructs and protein purification. All plasmids
used in this study are listed in Table 1, and all primers are listed in Table S1
in the supplemental material. PilC1 residues 739 to 1047 were cloned from
pUC19pilC1 with primers PilC1 738 F and PilC1 1047 R into a pMCSG9
LIC HIS MBP vector. Site-directed mutagenesis was performed to pro-
duce D930A and D930K mutations with primers PilC1D930A-F/
PilC1D930A-R and PilC1D930K-F/PilC1D930K-R, respectively. All
clones were confirmed with nucleotide sequencing. Resultant vectors
were transformed into BL21-RIPL cells (Stratagene) and plated on LB
agar plates containing 25 g/ml tetracycline, 50 g/ml streptomycin, 50
g/ml chloramphenicol, and 100 g/ml ampicillin. A single colony was
used to inoculate 50 ml of LB broth containing the previously mentioned
antibiotics, and cultures were incubated overnight. Cell cultures were cen-
trifuged at 3,000  g, and the supernatant was discarded. The resultant
pellet was used to inoculate a 1.5-liter shaker flask of Terrific broth (TB)
with 50 l antifoam (Sigma-Aldrich) and the previously mentioned anti-
biotics. Cells were grown at 37°C until the optical density at 600 nm
(OD600) reached 0.6 to 0.8. The temperature was then reduced to 18°C,
and protein expression was induced with 0.2 mM isopropyl--D-thioga-
lactopyranoside (IPTG). Cells were grown overnight and harvested by
centrifugation at 6,000  g at for 15 min at 4°C, and pellets were stored at
80°C.
Thawed PilC1 pellets were suspended in lysis buffer (50 mM sodium
phosphate [pH 7.6], 500 mM NaCl, 25 mM imidazole) supplemented
with 0.5 mM EDTA, 0.1% Triton X-100, 1 mM phenylmethylsulfonyl
fluoride (PMSF), one tablet of a protease inhibitor cocktail (Roche), and 1
g/ml lysozyme. After 1 h of gentle stirring on ice, the cells were sonicated
on ice for 1 min and the lysate was centrifuged at 45,000  g for 90 min at
4°C. Using an ÄKTAxpress (GE Healthcare), protein from the filtered
soluble fraction was nickel purified (elution buffer consisted of 50 mM
sodium phosphate [pH 7.6], 500 mM NaCl, and 500 mM imidazole) and
purified on an S200 gel filtration column in the final buffer, which con-
tained 20 mM Tris-HCl (pH 7.5), 250 mM NaCl, 2 mM dithiothreitol
(DTT), and 5% glycerol. Protein was then concentrated, flash frozen in
liquid nitrogen, and stored at 80°C.
PilC2 residues 868 to 1502 were cloned from genomic K. kingae DNA
with primers PilC2 868 F and PilC2 end R into a pMCSG7 LIC HIS vector.
Site-directed mutagenesis was performed to produce D1125A (primers
PilC2D1125A-F/PilC2D1125A-R), D1125K (primers PilC2D1125K-F/
PilC2D1125K-R), D1444A (primers PilC2D1444A-F/PilC2D1444A-R),
and D1444K (primers PilC2D1444K-F/PilC2D1444K-R) mutations. Re-
sultant plasmids were transformed into BL21-Gold cells (Agilent), which
were incubated overnight on LB plates containing ampicillin. Subse-
quently, a single colony was used to inoculate 100 ml LB broth overnight
containing 50 g/ml ampicillin, and the culture was incubated overnight.
Cell cultures were treated as described above except that they were in-
duced with 0.5 mM IPTG.
Cells pellets were thawed and resuspended in buffer consisting of 10
mM Tris (pH 7.8) and 50 mM NaCl with 10 mM imidazole, DNase, and
protease inhibitor tablets (Roche). Cells were sonicated, and the cell lysate
was separated into soluble and insoluble fractions using high-speed cen-
trifugation. The soluble fraction was filtered, then nickel purified (with
300 mM imidazole), buffer exchanged (no imidazole), and separated us-
ing an S200 gel filtration column on an ÄKTAxpress (GE Healthcare). If
necessary, protein and storage buffers were chelated with Chelex-100 to
remove bound calcium (Bio-Rad Laboratories). Purified proteins were
concentrated to 100 M, frozen, and stored at 80°C.
K. kingae strain construction. Gene disruptions and directed muta-
tions were generated in K. kingae as previously described (14, 15). Briefly,
plasmid-based disruption constructs were created in E. coli, linearized,
and introduced into K. kingae strain KK03 via natural transformation and
plating on appropriate antibiotic-containing media. Correct localization
of disruptions was confirmed by PCR or Southern blotting, and site-
directed mutations were confirmed by nucleotide sequencing. The pilF
and pilC1 deletion constructs were generated as previously described
(14). As our original pilC2 disruption was an insertional transposon mu-
tant (14), we decided to generate a targeted pilC2 deletion. PCR frag-
ments corresponding to the 5= and 3= regions of pilC2 were amplified
individually from strain KK03 with primers pilC25=F/pilC25=R and
pilC23=F/pilC2D3=R and were then ligated into EcoRI/HindIII-digested
pUC19, generating pUC19pilC2::BamHI, which contains a large pilC2
internal deletion and a BamHI site. The kanamycin resistance cassette
aphA3 was PCR amplified with primers aphA3FBamHI/aphA3RBamHI
from pFalcon2 and ligated into BamHI-digested pUC19pilC2::BamHI,
generating pUC19pilC2.
To generate pilC alleles that encode Ca-binding site mutations, anti-
biotic resistance markers were inserted adjacent to the pilC gene in a
pUC19 backbone, subjected to site-directed mutagenesis, sequenced, lin-
earized, and transformed into K. kingae strain KK03. For PilC1 Ca-bind-
ing site mutations, the entire pilC1 gene and 1,000 bp of 5= and 3=
flanking sequence were PCR amplified from KK03 genomic DNA with
primers pilC1regionF/pilC1regionR and the ligated into EcoRI/SalI-di-
gested pUC19, generating pUC19pilC1. The QuikChange XL-II site-di-
rected mutagenesis kit (Agilent) and primers pilC1markF/pilC1markR
were used to insert an MluI site in the gene upstream of the pilC1 pro-
moter region, a predicted ABC-type transporter, generating pUC19/
MluIpilC1. The ermC erythromycin resistance cassette was amplified
from pIDN4 with primers ermCF/ermCR and was ligated into MluI-di-
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gested pUC19/MluIpilC1, generating pUC19/ErmpilC1. Restriction di-
gestion and sequencing were used to confirm proper orientation of ermC.
To confirm that the ermC marker inserted upstream of WT pilC1 did not
alter the phenotypes observed in the pilC2 background, a control
pilC2/PilC1mark (pilC2 deleted and ermC upstream of pilC1) strain was
created and was confirmed to have phenotypes identical to those of the
pilC2 strain. Site-directed mutagenesis with primers PilC1D930A-F/
PilC1D930A-R and PilC1D930K-F/PilC1D930K-R was used to generate
the D930A and D930K mutations, respectively.
For the PilC2 Ca-binding site mutations, 2.6 kb of the 3= region of
pilC2 was amplified with primers pilC2markAF/pilC2markAR and 1.5
kb of sequence immediately downstream of the pilC2 open reading frame
(ORF) was amplified with primers pilC2markBF/pilC2markBR individu-
ally from KK03 genomic DNA and ligated into EcoRI/HindIII-digested
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Description Reference or source
E. coli strains
Dh5 E. coli F 80dlacZM15 (lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK
 mK
)
phoA supE441 thi-1 gyrA96 relA1
49
BL21-CodonPlus(DE3)-RIPL E. coli B F ompT hsdS(rB
 mB
) dcm Tetr gal 	(DE3) endA Hte [argU proLCamr]
[argU ileY leuW Strep/Specr]
Agilent
BL21-Gold(DE3) E. coli B F ompT hsdS(rB
 mB
) dcm Tetr gal 	(DE3) endA Hte Agilent
K. kingae strains





pilF KK03 with an aphA3 marked pilF deletion This work
pilT KK03 with an ermC marked pilT insertion 38
pilC1 KK03 with a tetM marked pilC1 deletion This work
pilC2 KK03 with an aphA3 marked pilC2 deletion This work
pilC1 pilC2 KK03 with a tetM marked pilC1 deletion and an aphA3 marked pilC2 deletion This work
pilC1 PilC2mark pilC1-bearing strain with an aphA3 insertion immediately downstream of WT pilC2 This work
pilC2 PilC1mark pilC2-bearing strain with an ermC insertion upstream of WT pilC1 This work
pilC1 PilC2D1444A pilC1 PilC2mark strain with a pilC2 mutation resulting in expression of
PilC2D1444A
This work
pilC1 PilC2D1444K pilC1 PilC2mark strain with a pilC2 mutation resulting in expression
of PilC2D1444K
This work
pilC2 PilC1D930A pilC2 PilC1 mark strain with a pilC1 mutation resulting in expression of
PilC1D930A
This work
pilC2 PilC1D930K pilC2 PilC1 mark strain with a pilC1 mutation resulting in expression of
PilC1D930K
This work
PilC1D930A PilC2D1444A Strain KK03 expressing PilC1D930A and PilC2D1444A This work
PilC1D930K PilC2D1444K Strain KK03 expressing PilC1D930K and PilC2D1444K This work
Plasmids
pMCSG7 Protein expression vector for 6 His N-terminal fusions and a TEV cleavage site 50
pMCSG9 Protein expression vector for MBP 6 His N-terminal fusions and a TEV cleavage site 51
pMCSG9/PilC1 For expression of MBP-PilC1739–1047 This work
pMCSG9/PilC1D930A For expression of MBP-PilC1739–1047 D930A This work
pMCSG9/PilC1D930K For expression of MBP-PilC1739–1047 D930K This work
pMCSG7/PilC2 For expression of HIS-PilC2868–1502 This work
pMCSG7/PilC2D1125A For expression of HIS-PilC2868–1502 D1125A This work
pMCSG7/PilC2D1125K For expression of HIS-PilC2868–1502 D1125K This work
pMCSG7/PilC2D1444A For expression of HIS-PilC2868–1502 D1444A This work
pMCSG7/PilC2D1444K For expression of HIS-PilC2868–1502 D1444K This work
pFalcon2 Source of aphA3 kanamycin resistance gene 52
pHSXtetM4 Source of tetM tetracycline resistance gene 53
pIDN4 Source of ermC erythromycin resistance gene 54
pUC19/pilF pilF deletion construct 36
pUC19/pilC1 pilC1 deletion construct 14
pUC19/pilC2 pilC2 deletion construct This work
pUC19/ErmpilC1 For introduction of ermC marked pilC1 locus This work
pUC19/pilC2Kan For introduction of aphA3 marked pilC2 locus This work
pUC19/PilC1D930A For introduction of PilC1D930A This work
pUC19/PilC1D930K For introduction of PilC1D930K This work
pUC19/PilC2D1444A For introduction of PilC2D1444A This work
pUC19/PilC2D1444K For introduction of PilC2D1444K This work
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pUC19, generating pUC19pilC2, which contains a BamHI site inserted 20
bp downstream of the pilC2 stop codon. The kanamycin resistance
cassette aphA3 was PCR amplified with primers aphA3FBamHI/
aphA3RBamHI from pFalcon2 and ligated into BamHI-digested
pUC19pilC2, generating pUC19pilC2Kan. To confirm that the aphA3
marker inserted immediately downstream of wild-type (WT) pilC2 did
not alter the phenotypes observed in the K. kingae pilC1 background, a
control pilC1 PilC2mark (pilC1 deleted and aphA3 inserted downstream
of pilC2) strain was created and confirmed to have phenotypes identical to
those of the pilC1 strain. Site-directed mutagenesis with primers
PilC2D1444A-F/PilC2D1444A-R and PilC2D1444K-F/PilC2D1444K-R
was used to generate the D1444A and D1444K mutations, respectively.
Calcium binding assay. A binding curve for Oregon green 488
BAPTA-5N, hexapotassium salt (Invitrogen) in 10 mM Tris (pH 7.8) and
50 mM NaCl was measured on a PHERAstar (BMGLabtech) at 488 nm.
Purified PilC1 or PilC2 was chelated with Chelex-100 resin (Bio-Rad) and
subsequently serially diluted 1.5- to 3-fold from 100 M to 1 nM, and
each dilution was combined with 20 M Oregon green and 2 M CaCl2
and measured at 488 nm on a PHERAstar (BMGLabtech) to obtain a 50%
effective concentration (EC50). The EC50 was then used to calculate the
respective Kd (dissociation constant) for calcium as described previously
(34).
CD and thermal denaturation. Protein samples were exchanged into
chelated 10 mM KxHxPO4–50 mM NaF (pH 7.7) buffer, where x is depen-
dent on pH, and brought to 5 M with or without the addition of 20 M
CaCl2. A wavelength scan from 200 to 260 nm was performed on a circu-
lar-dichroism (CD) spectrometer 62 DS (Aviv) at 16°C with a 10-s aver-
aging time. Melting temperatures were measured at 214 nm from 3°C to
95°C at 1-degree increments with a 10-s averaging time.
Pilus preparations. Derivatives of K. kingae strain KK03 were incu-
bated on chocolate agar for 17 to 18 h, and growth was suspended in 1.5 ml
50 mM Tris–150 mM NaCl (pH 8.0) to an OD600 of 1.0, vortexed at full
speed for 1 min, and centrifuged at 21,000  g for 2 min to pellet the
bacteria. A total of 1.25 ml of the bacterium-free supernatant was sub-
jected to 20% ammonium sulfate precipitation on ice for 2 h. Precipitated
pili were collected via centrifugation at 21,000  g for 5 min and resus-
pended in 1 SDS-PAGE loading buffer. Aliquots were separated on 15%
SDS-PAGE gels and stained with Coomassie blue. The observed protein
band was confirmed to be the major pilin subunit, PilA1, by Western
blotting with antiserum GP65 as described previously (15).
Twitching-motility assays. Twitching motility was assessed by a mod-
ified agar plate stab assay originally developed for P. aeruginosa (35).
Briefly, derivatives of K. kingae strain KK03 were incubated on chocolate
agar for 17 to 18 h, and growth was resuspended in 1 phosphate-buff-
ered saline (PBS) to an OD600 of 1.0. One microliter of the bacterial sus-
pensions was stab inoculated to the bottoms of tissue culture-treated
100-mm plates containing 10 ml chocolate agar with 1% agar and incu-
bated at 37°C with 5% CO2 for 48 h. To reduce zone-to-zone and plate-
to-plate variation, the twitching-motility plates were cooled at ambient
temperature for 24 h prior to stab inoculation, and each strain set replicate
was performed with the same batch of chocolate agar plates. Twitching-
motility-competent strains spread from the stab inoculation site at the
plate-agar interface. The agar was carefully peeled away, and the plate was
air dried and stained with crystal violet to visualize the twitching-motility
zones. Three diameter measurements were taken and averaged per twitch-
ing zone. All experiments were performed in triplicate, and error bars
represent standard errors of the means. Statistical analysis was performed
using analysis of variance (ANOVA) and Bonferroni’s posttest to compare
twitching zones between mutant and parental strains.
Eukaryotic cell lines. Chang cells (Wong-Kilbourne derivative [D] of
Chang conjunctiva, HeLa origin; ATCC CCL-20.2) were cultivated at
37°C with 5% CO2 in media as described previously (36).
Adherence assays. Quantitative adherence assays were performed as
described previously (14, 15). Briefly, monolayers of fixed Chang cells at a
density of 2  105/well in 24-well plates were inoculated with approxi-
mately 6.5  106 CFU of bacteria (multiplicity of infection [MOI] of
30), and plates were centrifuged at 165  g for 5 min and then incubated
for 25 min at 37°C in 5% CO2. Monolayers were washed 4 times with PBS
to remove nonadherent bacteria and were then treated with 1 trypsin-
EDTA (Sigma) for 20 min at 37°C to release adherent bacteria. Appropri-
ate dilutions were plated on chocolate agar, and percent adherence was
calculated by dividing the number of adherent CFU by the number of
inoculated CFU. All experiments were performed in triplicate. Statistical
analysis was performed using ANOVA and Bonferroni’s posttest to com-
pare adherence levels between mutant and parental strains.
Transmission electron microscopy (TEM). To assess surface pilia-
tion, K. kingae strains were resuspended in ammonium acetate, pH 7.4,
and allowed to absorb onto Formvar-carbon-coated 200-mesh grids for 1
min. The grids were subsequently stained with 1% uranyl acetate for 30 s,
excess liquid was wicked away, and the grids were air dried and examined
on a Philips CM12 transmission electron microscope (TEI) at an acceler-
ating voltage of 80 kV.
RESULTS
K. kingae PilC1 and PilC2 contain a calcium-binding site. Based
on sequence homology with P. aeruginosa PilY1 and N. meningi-
tidis and N. gonorrhoeae PilC1 and PilC2, K. kingae encodes two
PilC homologs called PilC1 and PilC2. Interestingly, while PilC1
and PilC2 in the pathogenic Neisseria species are nearly identical,
the K. kingae strain 269-492 PilC1 and PilC2 proteins share only
limited homology with each other and with other PilC-like pro-
tein family members (14). Most of the similarity between mem-
bers of this protein class resides in the C-terminal putative pilus-
interacting half of the proteins (34). Interestingly, while K. kingae
is a member of the Neisseriaceae family, the PilC1 and PilC2 C-ter-
minal domains are more similar to P. aeruginosa PilY1 than to the
Neisseria PilC1 and PilC2 proteins or even to each other (Fig. 1A
and C). The difference in length of PilC1 and PilC2 compared to P.
aeruginosa PilY1 reflects the presence of multiple nonhomolo-
gous sequences in PilC1 and PilC2 that are absent in PilY1. Exam-
ination of the K. kingae PilC1 and PilC2 amino acid sequences
revealed one predicted Ca-binding site in each protein (Fig. 1B
and D). PilC1 contains a 9-residue site (922-DVNRDGVYD-930)
that is similar to the Ca-binding loop in P. aeruginosa PilY1 (Fig.
1B), and PilC2 contains a 12-residue site (1433-DTNGDGK
FTEAD-1444) with strong homology to the canonical EF-hand
human calmodulin Ca-binding loop (Fig. 1D). An additional less
conserved 12-residue calmodulin-like Ca-binding site was also
identified in PilC2 (1114-DLTNPTDLTESD-1125) (Fig. 1D).
To determine if the putative PilC1 Ca-binding site binds cal-
cium, recombinant fragments of PilC1 were expressed in E. coli,
purified, and tested for Ca-binding potential in vitro. A C-termi-
nal PilC1 fragment containing amino acids 739 to 1047 was ex-
pressed as a maltose-binding protein (MBP) fusion, PilC1739 –1047-
MBP, and purified. As shown in Fig. 2A, PilC1739 –1047-MBP
exhibited a binding affinity for calcium with a Kd of 530 nM,
confirming that PilC1 binds calcium. The affinity of PilC1 is com-
parable to the affinity of PilY1, which has a Kd of 2.6 M (34).
Orans et al. demonstrated that mutation of the terminal bidentate
aspartic acid residue in the PilY1 9-amino-acid Ca-binding loop
to alanine eliminated Ca binding and created a calcium-free PilY1
state, while mutation of this residue to lysine also eliminated Ca
binding but created a potential calcium-bound mimic PilY1 state
(34). As shown in Fig. 2A, mutation of the terminal aspartic acid
residue D930 in the K. kingae PilC1 Ca-binding site to either ala-
nine or lysine eliminated specific Ca binding. The mutant
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PilC1739 –1047D930A-MBP and PilC1739 –1047D930K-MBP exhib-
ited wild-type CD spectra (see Fig. S1 in the supplemental mate-
rial), indicating that the overall structure of these fusion proteins
was not altered.
In order to characterize PilC2, a recombinant fragment con-
taining amino acids 868 to 1502 was purified. As shown in Fig. 2B,
purified PilC2868 –1502 exhibited a binding affinity for calcium with
a Kd of 5.5 M, confirming that PilC2 binds calcium. This Kd is
consistent with the previously published calmodulin values in the
low micromolar range (37). Mutation of the terminal bidentate
aspartic acid residue D1444 in the PilC2 Ca-binding loop to ala-
nine or lysine eliminated Ca binding. The PilC2868 –1502D1444A
and PilC2868 –1502D1444K proteins exhibited WT CD spectra and
melting temperatures (see Fig. S2 in the supplemental material),
indicating that the overall structure of these proteins was not al-
tered. The less conserved 12-amino-acid site located at positions
1114 to 1125 was demonstrated to have no effect on Ca binding
(Fig. 2C).
Taken together, these data indicate that PilC1 contains a func-
tional Ca-binding site located in the region corresponding to
amino acids 922 to 930 and that PilC2 contains a functional Ca-
binding site located in the region corresponding to amino acids
1433 to 1444.
Influence of K. kingae PilC1 and PilC2 Ca-binding sites on
type IV pilus production. To investigate the influence on and role
of the PilC1 and PilC2 Ca-binding sites in type IV pilus produc-
tion and other type IV pilus phenotypes in K. kingae, we generated
a series of mutants in the KK03 strain background, a naturally
occurring spreading and corroding derivative of 269-492 that pro-
duces stable levels of type IV pili. The pilC1 and pilC2 genes are
located in physically separate regions of the K. kingae genome, as
highlighted in the diagrams of the mutant derivatives of KK03 in
Fig. 3. To investigate the phenotypes associated with an individual
pilC locus, Ca-binding site mutations were introduced into the
pilC locus of interest with a nearby antibiotic resistance marker in
a strain background with the other pilC gene deleted. Strains con-
taining Ca-binding mutations in both PilC1 and PilC2 were also
generated for investigation. In addition to the strains diagrammed
in Fig. 3, a previously described pilF type IV pilus assembly
ATPase mutant that is unable to assemble type IV pili was used as
a control strain (14).
To assess production of type IV pili, fibers were sheared from
the surfaces of equal-OD600 suspensions of K. kingae KK03 deriv-
atives and separated using SDS-PAGE, and the major pilin sub-
unit was stained with Coomassie blue. In earlier work, we demon-
strated that the major band at 14 kDa is PilA1, the major pilin
subunit (15). As shown in Fig. 4, while the pilF and pilC1
pilC2 strains were nonpiliated, all mutants that produced at least
one PilC protein (whether WT or containing a mutation in the
Ca-binding site) were piliated. The type IV pilus retraction ma-
chinery mutant pilT was included as a control and was piliated
(38). In some strains, there appeared to be slight reductions in
quantity of extracellular PilA1 relative to the parental strains,
including pilC2 PilC1D930A, pilC2 PilC1D930K, and
PilC1D930A PilC2D1444A strains, indicating a minor defect in
surface pilus production (Fig. 4). However, all strains examined
produced surface pili, demonstrating that Ca-binding site mutant
PilC1 and PilC2 are still able to promote piliation. Examination of
this strain set using TEM revealed no noticeable changes in pilus
number per bacterium and no differences in pilus length or mor-
phology (data not shown). Together, these data indicate that at
least one PilC protein is required to promote piliation and that the
Ca-binding sites are dispensable for piliation.
The PilC1 and PilC2 Ca-binding sites influence twitching
motility. We next wanted to assess the role of the PilC Ca-binding
sites in twitching motility. Using a modified agar plate stab assay
originally developed for use in P. aeruginosa (35), we measured the
spreading zone at the plate-agar interface as a readout for twitch-
ing motility. We demonstrated the utility of this method for as-
sessing twitching motility by showing that a strain lacking PilT, the
type IV pilus retraction ATPase, still produced surface pili but was
unable to form a spreading zone (38). As shown in Fig. 5, the
pilC2 and control pilC2 PilC1mark strains produced statisti-
cally significantly larger twitching zones than did the parent strain
(P 
 0.05), while the pilC1 and pilC1 PilC2mark strains pro-
duced twitching zones that were slightly smaller than but were
not statistically significantly different from those of the parent
strain. These data indicate that PilC1 and PilC2 differentially
control twitching motility and that PilC2 serves to dampen
twitching motility when PilC1 is present. Interestingly, the
PilC1D930A and PilC1D930K mutations exhibited signifi-
cantly reduced twitching motility compared to the parent and
wild-type strains (P 
 0.05), similar to the nontwitching
FIG 1 (A) Sequence comparison of K. kingae PilC1 with P. aeruginosa PilY1
highlighting the C-terminal region with the greatest amount of homology (in
black). Sequence identity and similarity values are given for the region in black.
White bars represent putative and confirmed calcium-binding domains in K.
kingae and P. aeruginosa, respectively. (B) Alignment of the K. kingae PilC1
putative Ca-binding site with the calcium-chelating residues of P. aeruginosa
PilY1, with the potential calcium-chelating residues of PilC1 shown in bold.
(C) Sequence comparison of K. kingae PilC2 with P. aeruginosa PilY1 high-
lighting the C-terminal region with the greatest amount of homology (in
black). Sequence identity and similarity values are given for the region in black.
White bars represent putative and confirmed calcium-binding domains in K.
kingae and P. aeruginosa, respectively. The white bar with an asterisk in the K.
kingae PilC2 sequence represents a site homologous to a CaM calcium-binding
site that does not bind calcium. (D) Alignment of the K. kingae PilC2 putative
Ca-binding sites, with the calcium-chelating residues of human calmodulin
and the potential calcium-chelating residues of PilC2 shown in bold.
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pilF and pilC1 pilC2 strains. In contrast, the pilC1
PilC2D1444A strain demonstrated no defect in twitching mo-
tility compared to the parental pilC1 strain and control
pilC1 PilC2mark strain, while the pilC1 PilC2D1444K strain
had a modest but statistically significant (P 
 0.05) reduction
in twitching zone. Reduced twitching zones were also evident
for the PilC1D930A PilC2D1444A and PilC1D930K
PilC2D1444K double mutants compared to those of the paren-
tal and wild-type strains. Despite the smaller twitching zones in
these three mutants, the zones were significantly larger than the
zones produced by the twitching-deficient controls (P 
 0.05), indi-
cating reduced and not absent twitching motility. Compared to the
wild-type strain, the mutants fall into four distinct statistically signif-
icant categories: null (pilF,pilC1pilC2,pilC2 PilC1D930A, and
pilC2 PilC1D930K strains), WT (WT, pilC1, pilC1 PilC2mark,
and pilC1 PilC2D1444A strains), 
WT (pilC1 PilC2D1444K,
PilC1D930A PilC2D1444A, and PilC1D930K PilC2D1444K strains),
and WT (pilC2 and pilC2 PilC1mark strains). Together, these
data demonstrate that the PilC1 Ca-binding site is essential for
twitching motility, while the PilC2 Ca-binding site has only a minor
influence on twitching motility.
The PilC1 Ca-binding site but not the PilC2 Ca-binding site
is necessary for adherence. We next chose to investigate the in-
fluence of PilC1 and PilC2 Ca binding on adherence to human
epithelial cells. Using a previously established adherence assay (14,
15), we determined the relative levels of adherence to Chang epi-
thelial cells by the series of Ca-binding site mutants. Of note, we
previously observed reduced adherence of the 269-492pilC1 and
269-492pilC2::aphA3 mutants compared to strain 269-492 (14).
In contrast, in this study, the pilC1 derivative of KK03 had only
a slight defect in adherence, and the pilC2 derivative of KK03 had
no defect in adherence, compared to the KK03 parent (Fig. 6).
Examination of the adherence to Chang cells by the PilC Ca-bind-
ing mutants revealed stark differences between PilC1 and PilC2
(Fig. 6). The pilC2 PilC1D930A and pilC2 PilC1D930K strains
exhibited marked deficiencies in adherence compared to the
FIG 2 K. kingae PilC1 and PilC2 contain calcium-binding sites. Calcium competition binding assays using Oregon green were performed with WT, D930A, and D930K
recombinant PilC1739–1047-MBP (A); WT, D1444A, and D1444K recombinant PilC2868–1502 (B); and WT, D1125A, and D1125 recombinant PilC2868–1502 (C). Binding
curves were modeled to one-site competition or linear line. Error bars represent standard errors of the means.
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pilC2 and pilC2 PilC1mark control strains (P 
 0.05) and ad-
hered at levels similar to those of the nonpiliated pilF and pilC1
pilC2 controls. However, the pilC1 PilC2D1444A and pilC1
PilC2D1444K strains displayed normal adherence, comparable to
adherence by the parental pilC1 and pilC1 PilC2mark control
strains. The PilC1D930A PilC2D1444A and PilC1D930K
PilC2D1444K double mutants also adhered at levels similar to
those of the pilC1 strains that express either WT or mutant
PilC2, indicating that PilC2 is able to promote adherence in the
presence of Ca-binding mutant PilC1, regardless of PilC2 Ca-
binding state. These results demonstrate that the PilC1 Ca-bind-
ing site is necessary and the PilC2 Ca-binding site is dispensable
for adherence to Chang cells.
FIG 3 Representation of the pilC1 and pilC2 loci of K. kingae strain KK03 derivatives used in this study. The pilC1 and pilC2 genes are present at separate
loci in the genome. The pilC1 and pilC2 mutants are marked with a tetracycline resistance cassette (Tetr) and a kanamycin resistance cassette
(Kanr), respectively. Both deletion mutations were combined to generate the pilC1 pilC2 double mutant. pilC2 PilC1D930A and pilC2 PilC1D930K
strains, with a pilC2 PilC1mark strain (WT pilC1 with an erythromycin resistance cassette [Ermr] upstream of the promoter region) used as a control,
were generated to study the role of the PilC1 Ca-binding site in the absence of pilC2. pilC1 PilC2D1444A and pilC1 PilC2D1444K strains, with a pilC1
PilC2mark strain (WT pilC2 with the Kanr marker immediately downstream of pilC2) used as a control, were generated to study the role of the PilC2
Ca-binding site in the absence of pilC1. Mutations were combined to generate PilC1D930A PilC2D1444A and PilC1D930K PilC2D1444K
strains.
FIG 4 All PilC1 and PilC2 Ca-binding-site mutants produce surface pili. Pili
were sheared from the surface of K. kingae strain KK03 derivatives, and the
major pilin subunit, PilA1, was visualized with Coomassie blue staining fol-
lowing SDS-PAGE. pilF and pilC1 pilC2 strains both express PilA1 but fail
to assemble surface pili, and the pilT strain is a pilus retraction mutant and is
piliated. MS, molecular size (in kDa).
FIG 5 The PilC1 and PilC2 Ca-binding sites influence twitching motility. K.
kingae strain KK03 and derivatives were assessed for twitching motility using a
modified agar plate stab assay. Twitching-zone diameters were measured in
triplicate, and averages were calculated from three independent experiments.
Error bars represent standard errors of the means. Statistical analysis was per-
formed using ANOVA with Bonferroni’s posttest to compare twitching-mo-
tility zones between the mutants and the parental strains as noted in the text.
Asterisks indicate statistically significant (P 
 0.05) differences between the
mutants and the relevant parental strain.
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DISCUSSION
K. kingae produces type IV pili that mediate adherence to human
cells (14, 15). The PilC-like proteins play key roles in type IV pilus
biology in K. kingae and numerous other Gram-negative bacteria
of medical importance (17, 18). In this study, we found that PilC1
and PilC2 bind calcium in vitro and that significant differences in
type IV pilus phenotypes exist in the PilC1 and PilC2 Ca-binding-
site mutants. Both wild-type and Ca-binding mutant PilC1 and
PilC2 were able to promote pilus production when expressed in-
dividually. However, Ca-binding mutant PilC1 eliminated twitch-
ing motility and adherence, while Ca-binding mutant PilC2 had
little or no effect on twitching motility and no effect on adherence.
Strains that expressed both PilC1 and PilC2 Ca-binding mutants
demonstrated phenotypes identical to those of the PilC2 single
mutant. These data demonstrate important differences in PilC1
and PilC2 control of type IV pilus phenotypes in K. kingae.
In the pathogenic Neisseria species, PilC1 and PilC2 are highly
homologous to each other. N. gonorrhoeae PilC1 and PilC2 func-
tion interchangeably in promoting pilus biogenesis, natural com-
petence, and adherence (39, 40). N. meningitidis PilC1 and PilC2
both promote pilus production and natural competence but dif-
ferentially promote adherence to certain cell types (28, 30, 41, 42).
Sequence analysis suggests that differences in PilC1- and PilC2-
mediated adherence are based in the N-terminal portion of the
proteins (43). Given the highly homologous nature of the PilC
proteins in the pathogenic Neisseria species, especially in the C-
terminal portion of the protein and in the 9-amino-acid putative
Ca-binding loop, it is likely that Ca binding is an important factor
for Neisseria type IV pilus biology. In contrast, the related Neisse-
riaceae family member K. kingae expresses two PilCs that share
only limited sequence homology and are differentially controlled
by Ca binding. We speculate that differences in host niches may be
a driving factor influencing the mechanism of PilC function. K.
kingae inhabits the posterior pharynx as a commensal but tends to
cause disease primarily in the joints and bones, two calcium-rich
sites. Of note, human plasma has a free calcium concentration of
1.03 to 1.30 mM, and human joint fluid has a calcium concentra-
tion of 4 mM or higher (44). These high-calcium environments
may promote the Ca-dependent functions of PilC1, with no spe-
cific effect on PilC2. While calcium is the predominant divalent
cation associated with the 9-amino-acid and 12-amino-acid con-
sensus binding motifs, magnesium, zinc, and manganese may
bind to these motifs as well (32, 45–48). In future studies, we will
examine whether these additional divalent cations influence PilC1
or PilC2 function.
The first report that calcium plays a key role in regulating type
IV pilus production and twitching motility described the study of
PilY1, a PilC-like protein in P. aeruginosa (34). Orans et al. crys-
tallized the C-terminal domain of PilY1 and identified a 9-amino-
acid Ca-binding site. These investigators showed that mutation of
the bidentate aspartic acid residue in the Ca-binding loop to ala-
nine (D859A) resulted in significantly reduced pilus production
and twitching motility, mimicking the effect of a pilY1 mutation.
Mutation of the same residue to lysine resulted in increased pilus
production and reduced twitching motility, mimicking a pilT
pilus retraction mutation. Interestingly, K. kingae PilC1 contains a
similar 9-amino-acid site, and mutation of the predicted bidentate
residue to alanine or lysine eliminated twitching motility but did
not have a major impact on surface pilus production, thus con-
trasting with PilY1. Hence, while control of twitching motility in
PilY1 is due to the influence of the Ca-binding site on pilus pro-
duction, the K. kingae PilC1 Ca-binding site directly impacts
twitching motility and adherence, not surface pilus production.
Interestingly, expression of the alanine or lysine mutant proteins
in K. kingae resulted in identical phenotypes, again contrasting
with PilY1. Orans et al. modeled the PilY1 D859K mutation and
found that the amino group of the lysine side chain potentially
mimics a calcium ion, creating a pseudo-calcium-bound PilY1
state. One potential reason for the differences observed between
the K. kingae PilC1D930K mutant and the PilY1D859K mutant
may be differences in the structures of the regions surrounding the
Ca-binding loop in the two proteins, as the primary amino acid
sequence of the loop is largely conserved (Fig. 1B).
To dissect the roles of PilC1 and the Ca-binding site in K.
kingae type IV pilus-mediated twitching motility and adherence, it
is important to examine the relationship between the two pheno-
types. We have found that disruption of the K. kingae type IV pilus
retraction machinery, pilTU, results in increased surface piliation,
significantly reduced adherence, and loss of twitching motility
(38). Interestingly, adherence by the pilT mutant is reduced to
approximately 50% of the wild type (38) rather than eliminated, as
observed with the pilC2 PilC1D930A and pilC2 PilC1D930K
mutants (Fig. 6). Taken together, these data suggest that the ad-
herence defect of these two mutants is not completely a result of
the defect in twitching motility but is a consequence of altered
PilC1 adherence-promoting activity. In accord with these find-
ings, Johnson et al. found that in vitro Ca binding by P. aeruginosa
PilY1 influences RGD-mediated PilY1 binding to integrins, sup-
porting a specific role for the 9-amino-acid Ca-binding site in
adherence in this protein class (32).
In contrast to the situation with PilC1, the K. kingae PilC2
Ca-binding site is dispensable for twitching motility and adher-
ence. We originally identified two potential Ca-binding sites in
FIG 6 The PilC1 but not PilC2 Ca-binding site is essential for adherence. K.
kingae strain KK03 and derivatives were investigated for adherence to Chang
human epithelial cells using a quantitative adherence assay. Experiments were
performed in triplicate, and averages were calculated from three independent
experiments. Error bars represent standard errors of the means. Statistical
analysis was performed using ANOVA and Bonferroni’s posttest to compare
adherence levels between the mutants and the parental strains as noted in the
text. Asterisks indicate statistically significant (P 
 0.05) differences between
the mutants and the relevant parental strain.
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PilC2 with homology to the 12-amino-acid Ca-binding loop of
human calmodulin and no sites with homology to the PilY1-like
loop. In vitro analysis demonstrated that only one of these sites was
functional. However, our data clearly show that PilC2 is able to
promote pilus production, twitching motility, and adherence
when the confirmed Ca-binding site is mutated. These results sug-
gest that K. kingae PilC1 and PilC2 utilize different mechanisms in
relation to Ca binding to promote twitching motility and adher-
ence.
At this time, we can only speculate on the potential mecha-
nisms by which Ca binding by PilC1 and PilC2 influences type IV
pilus phenotypes. In the case of PilC1, we suggest that Ca binding
or Ca responsiveness may be essential for proper protein struc-
ture. In this model, the Ca-binding-site mutant PilC1 has an al-
tered protein conformation that retains the ability to promote
pilus assembly but is not able to promote twitching motility and
adherence. In contrast, PilC2 appears to function completely in-
dependently of Ca binding at the site identified in this report (Fig.
1B). We envision two potential scenarios to explain our findings:
(i) PilC2 contains an additional cryptic Ca-binding site in the
N-terminal 857 amino acids that were not included in the PilC2
fragment used for the in vitro Ca-binding studies, or (ii) PilC2
utilizes a novel mechanism that promotes twitching motility and
adherence regardless of the functionality of the Ca-binding site. In
the study by Johnson et al. that identified RGD-mediated PilY1
binding to integrins, analysis revealed a second Ca-binding site in
PilY1 (32). While sequence analysis of PilC2 did not reveal any
additional potential Ca-binding sites, we cannot rule out this pos-
sibility.
The results presented in this report establish key differences in
the role of Ca binding in the function of the K. kingae PilC1 and
PilC2 proteins. However, the precise mechanisms used by these
proteins to control type IV pilus phenotypes remain unclear and
will require future investigation. A greater understanding of K.
kingae PilC1 and PilC2 function may provide insights into species-
specific control mechanisms of type IV pilus phenotypes and sug-
gest novel strategies for prevention or treatment of K. kingae dis-
ease.
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